Albumin infusion ameliorates liver injury in streptozotocin-induced diabetic rats

Bae CS, Ahn T (2022): Albumin infusion ameliorates liver injury in streptozotocin-induced diabetic rats. Vet Med-Czech 67, 245–256.

download PDF

We investigated the effect of an albumin infusion on the enzyme activity, expression level of cytochrome P450 2E1 (CYP2E1), and oxidative stress in the serum and liver of streptozotocin (STZ)-induced diabetic rats. The STZ treatment enhanced the alanine aminotransferase and aspartate aminotransferase activities in the rat serum compared with those in the untreated rats. Treatment with STZ elevated the expression and catalytic activity of CYP2E1, and the oxidative stress, and decreased the reducing potentials in the liver, suggesting the possibility of diabetes-induced liver injury. Moreover, the antioxidant activity of the serum albumin decreased in the diabetic rats. In contrast, the administration of purified albumin from the intact rats to the diabetic rats restored these deleterious liver indices in an albumin concentration-dependent manner. These results suggest that an exogenous albumin infusion alleviates liver damage induced by type 1 diabetes.

Abdelmegeed MA, Carruthers NJ, Woodcroft KJ, Kim SK, Novak RF. Acetoacetate induces CYP2E1 protein and suppresses CYP2E1 mRNA in primary cultured rat hepatocytes. J Pharmacol Exp Ther. 2005 Oct;315(1):203-13.
Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121-6.
Afrin R, Arumugam S, Soetikno V, Thandavarayan RA, Pitchaimani V, Karuppagounder V, Sreedhar R, Harima M, Suzuki H, Miyashita S, Nomoto M, Suzuki K, Watanabe K. Curcumin ameliorates streptozotocin-induced liver damage through modulation of endoplasmic reticulum stress-mediated apoptosis in diabetic rats. Free Radic Res. 2015 Mar;49(3):279-89.
Ahn T, Yun CH, Oh DB. Tissue-specific effect of ascorbic acid supplementation on the expression of cytochrome P450 2E1 and oxidative stress in streptozotocin-induced diabetic rats. Toxicol Lett. 2006 Sep 30;166(1):27-36.
Aljomah G, Baker SS, Liu W, Kozielski R, Oluwole J, Lupu B, Baker RD, Zhu L. Induction of CYP2E1 in non-alcoholic fatty liver diseases. Exp Mol Pathol. 2015 Dec;99(3):677-81.
Anguizola J, Matsuda R, Barnaby OS, Hoy KS, Wa C, DeBolt E, Koke M, Hage DS. Review: Glycation of human serum albumin. Clin Chim Acta. 2013 Oct 21;425:64-76.
Bae JC, Seo SH, Hur KY, Kim JH, Lee MS, Lee MK, Lee WY, Rhee EJ, Oh KW. Association between serum albumin, insulin resistance, and incident diabetes in nondiabetic subjects. Endocrinol Metab (Seoul). 2013 Mar;28(1):26-32.
Barnett CR, Petrides L, Wilson J, Flatt PR, Ioannides C. Induction of rat hepatic mixed-function oxidases by acetone and other physiological ketones: Their role in diabetes-induced changes in cytochrome P450 proteins. Xenobiotica. 1992 Dec;22(12):1441-50.
Beauchamp C, Fridovich I. Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels. Anal Biochem. 1971 Nov;44(1):276-87.
Bhagwat SV, Vijayasarathy C, Raza H, Mullick J, Avadhani NG. Preferential effects of nicotine and 4-(N-methyl-N-nitrosamine)-1-(3-pyridyl)-1-butanone on mitochondrial glutathione S-transferase A4-4 induction and increased oxidative stress in the rat brain. Biochem Pharmacol. 1998 Oct 1;56(7):831-9.
Bhonsle HS, Korwar AM, Kote SS, Golegaonkar SB, Chougale AD, Shaik ML, Dhande NL, Giri AP, Shelgikar KM, Boppana R, Kulkarni MJ. Low plasma albumin levels are associated with increased plasma protein glycation and HbA1c in diabetes. J Proteome Res. 2012 Feb 3;11(2):1391-6.
Bourdon E, Blache D. The importance of proteins in defense against oxidation. Antioxid Redox Signal. 2001 Apr;3(2):293-311.
Bourdon E, Loreau N, Blache D. Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J. 1999 Feb;13(2):233-44.
Buttar HS, Chow AY, Downie RH. Glutathione alterations in rat liver after acute and subacute oral administration of paracetamol. Clin Exp Pharmacol Physiol. 1977 Jan-Feb;4(1):1-6.
Caro AA, Cederbaum AI. Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu Rev Pharmacol Toxicol. 2004 Feb;44:27-42.
Carvalho JR, Verdelho Machado M. New insights about albumin and liver disease. Ann Hepatol. 2018 Jul-Aug;17(4):547-60.
Chalasani N, Gorski JC, Asghar MS, Asghar A, Foresman B, Hall SD, Crabb DW. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis. Hepatology. 2003 Mar;37(3):544-50.
Cha MK, Kim IH. Glutathione-linked thiol peroxidase activity of human serum albumin: A possible antioxidant role of serum albumin in blood plasma. Biochem Biophys Res Commun. 1996 May 15;222(2):619-25. Erratum in: Biochem Biophys Res Commun 1996 Aug 14;225(2):695.
Chen J, Jiang S, Wang J, Renukuntla J, Sirimulla S, Chen J. A comprehensive review of cytochrome P450 2E1 for xenobiotic metabolism. Drug Metab Rev. 2019 May;51(2):178-95.
Comporti M, Signorini C, Leoncini S, Gardi C, Ciccoli L, Giardini A, Vecchio D, Arezzini B. Ethanol-induced oxidative stress: Basic knowledge. Genes Nutr. 2010 Jun;5(2):101-9.
DeFronzo R, Fleming GA, Chen K, Bicsak TA. Metformin-associated lactic acidosis: Current perspectives on causes and risk. Metabolism. 2016 Feb;65(2):20-9.
Desco MC, Asensi M, Marquez R, Martinez-Valls J, Vento M, Pallardo FV, Sastre J, Vina J. Xanthine oxidase is involved in free radical production in type 1 diabetes: Protection by allopurinol. Diabetes. 2002 Apr;51(4):1118-24.
Donato MT, Jimenez N, Serralta A, Mir J, Castell JV, Gomez-Lechon MJ. Effects of steatosis on drug-metabolizing capability of primary human hepatocytes. Toxicol In Vitro. 2007 Mar;21(2):271-6.
Guengerich FP, Kim DH, Iwasaki M. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol. 1991 Mar-Apr;4(2):168-79.
Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974 Nov 25;249(22):7130-9.
Hayashi T, Suda K, Imai H, Era S. Simple and sensitive high-performance liquid chromatographic method for the investigation of dynamic changes in the redox state of rat serum albumin. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 May 25;772(1):139-46.
Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci. 2002 Feb;65(2):166-76.
Jun HS, Khil LY, Yoon JW. Role of glutamic acid decarboxylase in the pathogenesis of type 1 diabetes. Cell Mol Life Sci. 2002 Nov;59(11):1892-901.
Kakkar R, Mantha SV, Radhi J, Prasad K, Kalra J. Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes. Clin Sci (Lond). 1998 Jun;94(6):623-32.
Kamath SA, Kummerow FA, Narayan KA. A simple procedure for the isolation of rat liver microsomes. FEBS Lett. 1971 Sep 15;17(1):90-2.
Leung TM, Nieto N. CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease. J Hepatol. 2013 Feb;58(2):395-8.
Lieber CS. Cytochrome P-4502E1: Its physiological and pathological role. Physiol Rev. 1997 Apr 1;77(2):517-44.
Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D, Gargiulo G, Testa G, Cacciatore F, Bonaduce D, Abete P. Oxidative stress, aging, and diseases. Clin Interv Aging. 2018 Apr 26;13:757-72.
Low PA, Nickander KK, Tritschler HJ. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes. 1997 Sep;46(Suppl_2):S38-42.
Mari M, Cederbaum AI. Induction of catalase, alpha, and microsomal glutathione S-transferase in CYP2E1 overexpressing HepG2 cells and protection against short-term oxidative stress. Hepatology. 2001 Mar;33(3):652-61.
McGarry JD, Guest MJ, Foster DW. Ketone body metabolism in the ketosis of starvation and alloxan diabetes. J Biol Chem. 1970 Sep 10;245(17):4382-90.
Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth. 2000 Oct;85(4):599-610.
Niemela O, Parkkila S, Juvonen RO, Viitala K, Gelboin HV, Pasanen M. Cytochromes P450 2A6, 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases. J Hepatol. 2000 Dec;33(6):893-901.
Omoruyi FO, Budiaman A, Eng Y, Olumese FE, Hoesel JL, Ejilemele A, Okorodudu AO. The potential benefits and adverse effects of phytic acid supplement in streptozotocin-induced diabetic rats. Adv Pharmacol Sci. 2013;2013:172494.
Osna NA, Donohue TM Jr. CYP2E1-catalyzed alcohol metabolism: Role of oxidant generation in interferon signaling, antigen presentation and autophagy. Subcell Biochem. 2013;67:177-97.
Park KT, Yun CH, Bae CS, Ahn T. Decreased level of albumin in peripheral blood mononuclear cells of streptozotocin-induced diabetic rats. J Vet Med Sci. 2014 Aug;76(8):1087-92.
Raoufinia R, Mota A, Keyhanvar N, Safari F, Shamekhi S, Abdolalizadeh J. Overview of albumin and its purification methods. Adv Pharm Bull. 2016 Dec;6(4):495-507.
Raza H, Prabu SK, Robin MA, Avadhani NG. Elevated mitochondrial cytochrome P450 2E1 and glutathione S-transferase A4-4 in streptozotocin-induced diabetic rats: Tissue-specific variations and roles in oxidative stress. Diabetes. 2004 Jan;53(1):185-94.
Reinke LA, Moyer MJ. p-Nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by ethanol. Drug Metab Dispos. 1985 Sep-Oct;13(5):548-52.
Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008 Jun 11;582(13):1783-7.
Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, Castells L, Vargas V, Soriano G, Guevara M, Gines P, Rodes J. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999 Aug 5;341(6):403-9.
Surbrook SE Jr, Olson MJ. Dominant role of cytochrome P-450 2E1 in human hepatic microsomal oxidation of the CFC-substitute 1,1,1,2-tetrafluoroethane. Drug Metab Dispos. 1992 Jul-Aug;20(4):518-24.
Tayeh N, Rungassamy T, Albani JR. Fluorescence spectral resolution of tryptophan residues in bovine and human serum albumins. J Pharm Biomed Anal. 2009 Sep 8;50(2):107-16.
Vincent JL, Wilkes MM, Navickis RJ. Safety of human albumin – Serious adverse events reported worldwide in 1998–2000. Br J Anaesth. 2003 Nov;91(5):625-30.
von Hoegen I, Waller C. Safety of human albumin based on spontaneously reported serious adverse events. Crit Care Med. 2001 May;29(5):994-6.
Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology. 1998 Jan;27(1):128-33.
Yanardag R, Ozsoy-Sacan O, Bolkent S, Orak H, Karabulut-Bulan O. Protective effects of metformin treatment on the liver injury of streptozotocin-diabetic rats. Hum Exp Toxicol. 2005 Mar;24(3):129-35.
download PDF

© 2022 Czech Academy of Agricultural Sciences | Prohlášení o přístupnosti